4-oxo-7-methoxy-1,4-dihydroquinoline-6-methyl formate synthesis method

A technology of methyl methoxybenzoate and methyl nitrobenzoate, which is applied in the field of pharmaceutical synthesis and achieves the effects of improving the utilization efficiency of raw materials, high yield, and being conducive to enlarged production

CN106543080AActive Publication Date: 2017-03-29SHANDONG BOYUAN PHARM CO LTD
4 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2017-03-29

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a 4-oxo-7-methoxy-1,4-dihydroquinoline-6-methyl formate synthesis method. The method includes that 4-nitro-methyl-2-methoxybenzoate which is taken as a starting material is subjected to friedel-crafts reaction, reduction and ammonolysis cyclization to obtain a target compound. By adoption of classic reaction, a step of decarboxylation in diphenyl ether at a high temperature of 180-220 DEG C in an existing universal method is avoided, problems in production are solved, safety and environment friendliness are achieved, and production enlargement is benefited. In addition, the synthesis method has advantages of high reaction efficiency, high yield, high purity, low cost and the like.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a method for synthesizing lenvatinib intermediate 4-oxo-7-methoxy-1,4-dihydroquinoline-6-carboxylic acid methyl ester, belonging to the technical field of drug synthesis. Background technique

[0002] Lenvatinib, the chemical name is 4-[3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide, and its structural formula is as follows:

[0003]

[0004] It is an orally effective multi-kinase inhibitor developed by Eisai Corporation of Japan, targeting vascular endothelial growth factor receptor (VEGFR) 1-3, fibroblast growth factor receptor (FGFR) 1-3, stem cell Growth factor receptor and beta-type platelet-derived growth factor receptor (PDGFR). It is used for the treatment of solid tumors such as glioma, thyroid tumor, renal cancer, liver cancer and ovarian cancer, and it is preferred for differentiated thyroid cancer that cannot be treated by radioactive iodine. In February 2013, it was approve...

Examples

Embodiment 1

[0029] a) Put 2kg of toluene and 211g of methyl 2-methoxy-4-nitrobenzoate into the dry reaction flask, cool down to below 0°C, drop in 200g of anhydrous aluminum chloride, control the temperature at 0-5°C, and Add 137 grams of 3-chloroacryloyl chloride dropwise into the reaction bottle, slowly warm up to room temperature and stir for 16 hours after dropping, cool down to 0-5°C, pour the reaction solution into 2000ml of cold 6N hydrochloric acid, stir for 1 hour, pump The product was obtained by filtration, washed with purified water until neutral, and dried at 60°C to obtain 270 g of compound II with a yield of 90%.

[0030] b) Put compound II, 299g, into the reaction flask, add 2000g of 20% ethanol water, add 60g of ammonium chloride, control the internal temperature to be less than 45°C, add 160g of reduced iron powder in batches, and slowly raise the temperature to 85°C for reaction After 3 hours, the iron sludge was filtered while it was hot, and the mother liquor was cool...

Embodiment 2

[0033] a) In a dry reaction flask, 220 g of methyl 2-methoxy-4-nitrobenzoate is dropped into 2 kg of dichloromethane containing 183 g of boron trichloride, and the temperature is controlled at 0-5° C., and the 3- Add 169 grams of chloroacryloyl chloride dropwise into the reaction bottle, stir at room temperature for 12 hours after dropping, cool down to 0-5°C, pour the reaction solution into 2000ml of cold 6N hydrochloric acid, stir for 1 hour, filter the product with suction, and purify Washed with water until neutral, and dried at 60°C to obtain 281 g of compound II with a yield of 90.1%.

[0034] b) Put 299g of compound II into the reaction flask, add 2000g of 20% ethanol water, add 64g of ammonium chloride, control the internal temperature to be less than 45°C, add 163g of reduced zinc powder in batches, and slowly heat up to 80°C for reaction After 4 hours, it was filtered while it was hot, and the mother liquor was cooled to below 0°C to obtain the product by suction fil...

Embodiment 3

[0037] a) Put 3kg of chloroform and 232g of methyl 2-methoxy-4-nitrobenzoate into the dry reaction bottle, cool down to -10°C, put in 219g of anhydrous aluminum trichloride, and control the temperature at 0-25°C , Add 164 grams of 3-chloroacryloyl chloride dropwise into the reaction flask, stir at room temperature for 1.2 hours after dropping, slowly raise the temperature to 45°C and stir for 4.5 hours, cool down to 1°C, and pour the reaction solution into 2000ml of cold 6N hydrochloric acid , stirred for 1.2 hours, and the product was obtained by suction filtration, washed with purified water until neutral, and dried at 60°C to obtain 301 g of compound II with a yield of 91.4%.

[0038] b) Put 300g of compound II into the reaction flask, add 2000g of 20% ethanol water, add 62g of ammonium chloride, control the internal temperature to be less than 45°C, add 200g of sodium sulfide in batches, and slowly raise the temperature to 83°C after the addition is complete. Reaction 3.4 ...